CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 105.10B | 102.24B | 98.43B | 94.07B | 96.96B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.10B | 102.24B | 98.43B | 94.07B | 96.96B |
| Cost of Revenue | 92.13B | 89.07B | 85.32B | 80.19B | 84.81B |
| Gross Profit | 12.97B | 13.17B | 13.11B | 13.88B | 12.14B |
| SG&A Expenses | 11.32B | 10.86B | 10.35B | 10.58B | 10.36B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.45B | 99.92B | 95.67B | 90.78B | 95.18B |
| Operating Income | 1.65B | 2.32B | 2.76B | 3.29B | 1.78B |
| Income Before Tax | 1.35B | -3.48B | 1.65B | 2.62B | 2.13B |
| Income Tax Expenses | -1.57B | 508.00M | 634.00M | 835.00M | 503.00M |
| Earnings from Continuing Operations | 2.92B | -3.99B | 1.01B | 1.78B | 1.62B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00M | 15.00M | 8.00M | -3.00M | 21.00M |
| Net Income | 2.94B | -3.98B | 1.02B | 1.78B | 1.64B |
| EBIT | 1.65B | 2.32B | 2.76B | 3.29B | 1.78B |
| EBITDA | 2.80B | 3.45B | 3.93B | 4.45B | 2.93B |
| EPS Basic | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 |
| Normalized Basic EPS | 0.69 | 1.09 | 1.25 | 1.51 | 0.86 |
| EPS Diluted | 2.29 | -3.13 | 0.80 | 1.41 | 1.31 |
| Normalized Diluted EPS | 0.68 | 1.09 | 1.24 | 1.51 | 0.86 |
| Average Basic Shares Outstanding | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B |
| Average Diluted Shares Outstanding | 1.29B | 1.27B | 1.27B | 1.26B | 1.26B |
| Dividend Per Share | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| Payout Ratio | 28.71% | -21.28% | 84.82% | 47.22% | 50.97% |